The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile

ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile

Publishing Date : Oct, 2018

License Type :
 

Report Code : 768554

Synopsis
Summary

ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). It’s products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto, Ontario, Canada.

ProMIS Neurosciences Inc (PMN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Geographical Area
Canada
Index
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 14
Equity Offering 15
ProMIS Neurosciences Raises USD5.6 Million in Private Placement of Shares and Warrants 15
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 19
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 20
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 21
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 22
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 23
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 24
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 27
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 28
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 29
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 31
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 32
ProMIS Neurosciences Inc - Key Competitors 34
ProMIS Neurosciences Inc - Key Employees 35
ProMIS Neurosciences Inc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Aug 14, 2018: Promis Neurosciences reports second quarter 2018 financial results 37
May 11, 2018: ProMIS Neurosciences Announces First Quarter 2018 Results 39
Mar 14, 2018: ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results 41
Nov 13, 2017: ProMIS Neurosciences Announces Third Quarter 2017 Results 43
Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 45
Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 47
May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 48
Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 49
Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 50
Corporate Communications 52
Sep 13, 2018: ProMIS Neurosciences appoints James Kupiec, MD as Chief Medical Officer 52
Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 53
Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 54
Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 55
Other Significant Developments 56
Aug 29, 2018: ProMIS Neurosciences Issues Narrated Overview of Second Quarter 2018 Results 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
List of Tables
List of Tables
ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2017 2
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ProMIS Neurosciences Inc, Deals By Market, 2012 to YTD 2018 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 14
ProMIS Neurosciences Raises USD5.6 Million in Private Placement of Shares and Warrants 15
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 19
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 20
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 21
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 22
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 23
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 24
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 27
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 28
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 29
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 31
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 32
ProMIS Neurosciences Inc, Key Competitors 34
ProMIS Neurosciences Inc, Key Employees 35
ProMIS Neurosciences Inc, Subsidiaries 36

List of Figures
List of Figures
ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
ProMIS Neurosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

Published By : GlobalData